RRIDs were included in the Cancer Research paper "Transcriptional reprogramming differentiates activ…" (https://t.co/0GijUvX9NL). RRIDs like this improve reproducibility in scientific research. #methodsmatter #ReproducibleResearch
Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer https://t.co/yatpvBOmka https://t.co/0sSBUK3oMn
Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer https://t.co/5FiGxsad0f https://t.co/qwnb52OUsA
Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer https://t.co/tlMpTo3vS0
Here is the link to Gou paper link on ESR1 translocations and their diagnosis and functional significance https://t.co/zQ5r15SFuF. Congrats Xuxu on the publication.
New 3i Investigator Article Alert!! Transcriptional reprogramming differentiates active from inactive ESR1 fusions in endocrine therapy-refractory metastatic breast cancer https://t.co/1YRnJI8ZR6 #sciencetwitter #academictwitter